SNP Variants in RET and PAX2 and Their Possible Contribution to the Primary Hyperoxaluria Type 1 Phenotype

Area of Science:

• Nephrology
• Medical Genetics
• Molecular Biology

Background:

• Primary hyperoxaluria type 1 (PH1) is a rare genetic kidney disease.
• It results from a deficiency in the alanine:glyoxylate aminotransferase (AGT) enzyme.
• Clinical presentation heterogeneity in PH1 is not fully explained by AGT gene variations alone.

Purpose of the Study:

• To investigate the contribution of Single Nucleotide Polymorphisms (SNPs) in RET and PAX2 genes to the clinical phenotype heterogeneity in PH1.
• To assess the association of these SNPs with reduced nephron number and age of onset in PH1 patients.

Main Methods:

• Genotyping analysis was performed on DNA samples from PH1 patients and healthy controls.
• Frequencies of specific SNPs in RET and PAX2 genes were compared between PH1 patients and controls.
• SNP frequencies were also analyzed in relation to the age of onset in PH1-affected individuals.

Main Results:

• Risk allele frequencies for RET and PAX2 SNPs showed a trend towards higher prevalence in early-onset PH1, though not statistically significant.
• Homozygosity for RET and PAX2 risk alleles was absent in the late-onset PH1 group.
• Significantly higher frequencies of PAX2 risk alleles and homozygotes were observed in PH1 samples compared to controls.

Conclusions:

• Genetic variations in RET and PAX2 may contribute to the clinical variability observed in Primary hyperoxaluria type 1.
• The increased prevalence of PAX2 risk alleles in PH1 patients suggests a potential association with more severe disease phenotypes.
• Further research is warranted to elucidate the precise role of these genetic factors in PH1 pathogenesis and progression.